Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Actinium Announces Positive Full Data Results From the Pivotal Phase 3 SIERRA Trial in Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia
Actinium Pharmaceuticals, a leader in the development of targeted radiotherapies, today announced positive results for […]
Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer
Abivax SA, a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the […]
Charter Healthcare Names New CEO and COO
Charter Healthcare, the post-acute provider platform of Pharos Capital Group, LLC, announced today that it […]
Terumo Blood and Cell Technologies' IMUGARD Platelet Pooling Set Cleared by FDA
Today, Terumo Blood and Cell Technologies have announced US Food and Drug Administration (FDA) clearance […]
Aera Therapeutics Launches with $193 Million in Financing to Enable and Advance the Next Generation of Transformative Genetic Medicines
Aera Therapeutics announced its launch today with a vision to harness its proprietary delivery platform […]
Aqilion announces Pre-clinical Licensing and Strategic Research Collaboration Agreement with Merck
Aqilion today announced an exclusive license and strategic research collaboration with Merck to discover, develop […]
LIfT BioSciences and Minaris Regenerative Medicine Enter into a Development and Manufacturing Partnership
LIfT BioSciences, a pioneering pre-clinical stage company moving into first-in-human trials with an allogeneic neutrophil […]
Previa Medical Raises €2.1 Million for AI Solution to Prevent Sepsis
Previa Medical, a deeptech start-up specialized in developing predictive medical devices for alerting healthcare providers […]
Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration
Charles River Laboratories International and Purespring Therapeutics, a pioneering gene therapy company focused on transforming […]
Celanese Announces a Research Agreement with Johns Hopkins University to Advance Sustained Ocular Drug Delivery to the Suprachoroidal Space
Celanese Corporation, a global specialty materials and chemical company, today announced an agreement with Johns […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more